SlideShare a Scribd company logo
1 of 16
NOIDA INSTITUTE OF ENGINEERING AND TECHNOLOGY
Pharmacological Screening of Anti Arrhythmic Drug
Presented by- Submitted to-
Jatin Saini Dr. Saumya Das
M.Pharm (Pharmacology) Associate Professor
1st sem
ARRHYTHMIA
 A heart arrhythmia is an irregular heartbeat. Heart rhythm problems occur when the electrical signals that
coordinate the heart's beats don't work properly.
 The faulty signaling causes the heart to beat too fast (tachycardia), too slow (bradycardia) or irregularly..
 Types
• Tachycardia is a fast heart. The resting heart rate is greater than 100 beats a minute.
• Bradycardia is a slow heartbeat. The resting heart rate is less than 60 beats a minute.
Screening Model
In vivo Model In vitro Model
1. CHEMICALLY INDUCED ARRHYTHMIA
• Aconitine antagonism in rats
• Digoxin induced arrhythmias in guine pigs
• Strophanthin induced Arrhythmia
• Adrenaline induced Arrhythmia
2. ELECTRICALLY INDUCED ARRHYTHMIA
• Ventricular fibrillation electrical threshold.
• Programmed Electrical Stimulation Induced
Arrhythmia
• Sudden Coronary Death Models in Dogs
3. EXERCISE INDUCED VENTRICULAR
FIBRILATION
4. MECHANICALLY INDUCED ARRHYTHMIA
1. Reperfusion Arrhythmia in Rats
2. Reperfusion Arrhythmia in Dog
1. Acetylcholine or Potassium Induced Arrhythmias
2. LANGENDROFF Technique
In vivo Model
1. Chemically Induced Arrhythmia
 Large number of agents alone or combination are capable to induced arrhythmia:
 Anesthetic like Chloroform, ether, Halothane.
 IV Adrenaline, Ouabain alkaloids
Aconitine antagonism in rats
Purpose:
Aconitine, its plant alkaloid from roots, it acts persistent on Na+ channels resulting ventricular arrhythmias.
Drugs which have anti-arrhythmetic property can be tested on aconitine intoxicated rats.
Procedure
Male Ivanovas rats (300-400 gm) are used
Anesthetized intraperitonially with urethane (1.25 g/kg)
Aconitine dissolved (5 mcg/kg) in 0.1 N HNO, & infused into rat's saphenous vein 0.1 ml/min
Lead II ECG is recorded every 30 sec.
Test compound injected orally 5 min before Aconitine infusion
Evaluation
Higher dose of aconitine in the test group gives an index of antiarrhythmic activity.
The antiarrhythmic effect of test compound is measured by the amount of aconitine /100g animal.
Higher dose of aconitine is needed as compared with control group.
Digoxin induced arrhythmias in guine pigs
Purpose
Overdose of cardiac glycosides, such as digoxin, induces ventricular extrasystoles, ventricular fibrillation, and finally death.
The occurrence of these symptoms can be delayed by antiarrhythmic drugs.
Procedure
Male Marioth guinea pigs (350-500 g) anesthetize with pentobarbitone 35mg/kg intraperitonially
Tracheae, Jugular vein & carotid artery catheterized & animal is maintained on artificial respiration (45 breath/min)
Through jugular vein digoxin is infused at rate 85mcg/kg in 0.266 ml/min until cardiac arrest
ECG recorded with steel needle during experiment
Test drug is administered either 1hr before if orally or 1min before if IV, prior infusion of digoxine
The onset of ventricular extrasystoles, fibrillation, cardiac arrest
Compared results in test & control group
Evalution
Using Student’s t-test, the doses of digoxin needed to induce ventricular extrasystoles, fibrillation, or cardiac arrest,
respectively after treatment with antiarrhythmic drugs are compared statistically with controls receiving digoxin only
Electrically induced arrhythmia
 Serial electrical stimulation results in flutter and fibrillation and it is possible to reproduce some of the
main type of arrhythmias of clinical importance. The flutter threshold or the ventricular multiple
response threshold may be determine in anesthetized dogs before or after administration of test
drug.
1. Ventricular fibrillation electrical threshold
2. Programmed Electrical Stimulation Induced Arrhythmia
3. Sudden Coronary Death Models in Dogs
Ventricular fibrillation electrical threshold
Purpose
The use of antiarrhythmic drugs in the treatment of ventricular arrhythmias aims to prevent the
development of ventricular fibrillation. Several electrical stimulation techniques have been used to
measure ventricular fibrillation threshold such as
 single pulse stimulation,
 train of pulses stimulation,
 continuous 50 Hz stimulation,
 sequential pulse stimulation
Procedure
 Dogs (8-12 kg) anesthetized with pentobarbitone intraperitonially and maintained on artificial
 Chest opened & heart is suspended on pericardial cradle
 SA node crushed & Ag-AgCl stimulating electrode embedded with Teflon disc sutured to anterior
of LV
 Anodal constant current for 400ms is applied through electrode and which was programmed by digital
stimulator
 ECG recorded through lead Il of body ECG monitoring
 To determine Ventricular Fibrillation (VFT) 0.2 to 1.8 s train of 50Hz pulses delivered
 The current intensity of pulse train required to induce sustained ventricular fibrillation is define as VFT
 When VF occurs, heart immediately defibrillate & allow to recover as controlled condition for 15-20
 Test drug administered through femoral vein
Evaluation
VFT is determined before and after administration of test drug & compared by using student T-Test
EXERCISE INDUCED VENTRICULAR FIBRILATION
Purpose:
This developed methods to evaluate antiarrhythmic drugs for their activity in cardiovascular parameters
in an exercise-plus ischemia test.
Procedure:
 Mongral dogs (15-19 kg) anesthetized with pentobarbitone IV (10mg/kg)
 Chest cavity opened, heart exposed & supported with pericardial cradle
 Around LCX 20 MHz pulsed Doppler flow transducer & hydraulic accluder are placed
 Pair of insulated silver wire sutured to epicardial surface of both left and right ventricle. ECG & HR is
determined
 Pre calibrated solid state pressure transducer is inserted into left ventricle finally, a two stage
occlusion of LAD is performed
 Leads from cardiovascular instrumentation are tunneled under skin to exit on the back of animal's
neck
 3-4 weeks after the production of myocardial ischemia; animal are walked on treadmill & trained to
lie quietly on lab table during recovery period
 Protocol starts with 3 min warm up followed by run at 6.4 km/hr (0% grade)
 Grade is increased every 3min run 0% 4% 8% 12% and 16%
 During last min of exercise LCX is occlusion treadmill stopped & occlusion maintained for additional
1min
 Occlusion is released if VF occurs
 Exercise and ischemia test is repeated after pretreated with test drug & compared with control
reading
In vitro Model
 Acetylcholine or Potassium Induced Arrhythmias
 LANGENDROFF Technic
Acetylcholine or Potassium Induced Arrhythmias
 New Zealand white rabbits (0.5-3kg) sacrificed and heart removed
 Atria dissected from other tissue in RL and attached with electrode
 Fibrillation produced when atria exposed with Acetylcholine or KCL
 After 5min exposure to Acetylcholine or KCL, atria stimulated with pulses 0.75 ms, usually of 100and
recorded on kymograph
 Control arrhythmia produced for 6-10 min followed by 30 min rest period
 Test compound were added to the bath
 If fibrillation doesn't disappear within 8-10 min, preparation is washed to allowed to normal
concentration.
 Test drug found to be effective If fibrillation is disappears immediately or within 5min
LANGENDROFF Technique
 Basic principal involved is that heart is perfused in RETROGRADE Direction from aorta either at constant
pressure or constant flow with oxygenated saline solution. It closes aortic valves, just in situ heart during
diastole. The perfusate is displaced through the coronary sinus and the opened right atrium.
 Procedure
 Guinea pigs either sex 300-500 g
 Heart is removed ASAP and placed in petridish containing RL at 37.0°C Aorta located and cut below the
division
 Cannula inserted into the aorta and tied. Heart is perfused with oxygenated RL
 Heart is transferred to double wall Plexiglass perfussion apparatus maintained 37.0°C
 Ligature is placed around LAD coronary artery occlusion is maintained for 10 min by reperfussion
 Test compound administered through perfusion medium either before or after occlusion.
 Epicardial ECG electrode is used for pulsatile stimulation and induction of arrhythmia [Rectangular pulses
0.75 msec duration, 10 V, 400-1800 shocks/min]
 Small steel hook with string attached to apex of heart and HR measured with chronometer
 Incidence & duration of VF or VT is recorded in control & test group
References
 Drug Discoveryand Evaluation: pharmacological assays by H Gerhard Vogel
 http://www.slideshare.net/DrAbhishekVyas/drug-screening-methods-for-antiarrhythmic-
agents?from_m_app=android
THANKYOU

More Related Content

What's hot

Pharmacological screening of anti arrhythmic drug
Pharmacological screening of anti arrhythmic drugPharmacological screening of anti arrhythmic drug
Pharmacological screening of anti arrhythmic drugRakesh Kumar
 
Screening of Antihyperlipidemic drugs
Screening of Antihyperlipidemic drugsScreening of Antihyperlipidemic drugs
Screening of Antihyperlipidemic drugsAbu Sufiyan Chhipa
 
Screening Methods of Anti Anxiety Agents
Screening Methods of Anti Anxiety AgentsScreening Methods of Anti Anxiety Agents
Screening Methods of Anti Anxiety AgentsAnupam dubey
 
Antiulcer screening models
Antiulcer screening modelsAntiulcer screening models
Antiulcer screening modelsDRx Priya Shukla
 
Preclinical Screening of Antipsychotic Agents
Preclinical Screening of Antipsychotic Agents Preclinical Screening of Antipsychotic Agents
Preclinical Screening of Antipsychotic Agents Anurag Chourasia
 
Experimental evaluation of anti arrhythmic drugs
Experimental evaluation of anti arrhythmic drugsExperimental evaluation of anti arrhythmic drugs
Experimental evaluation of anti arrhythmic drugsKirtan Bhatt
 
pre clinical Screening for anti asthmatic drugs
pre clinical Screening  for anti asthmatic drugspre clinical Screening  for anti asthmatic drugs
pre clinical Screening for anti asthmatic drugsDHINESHKUMAR V
 
Antidiabetic screening
Antidiabetic screeningAntidiabetic screening
Antidiabetic screeningshubhaasharma
 
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDScreening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDAbdul Hameed
 
Evaluation of antiarrhythmicdrugs
Evaluation of antiarrhythmicdrugsEvaluation of antiarrhythmicdrugs
Evaluation of antiarrhythmicdrugsshaffain
 
Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsHimikaRathi
 
SCREENING OF DRUGS USED IN ANTIARRYTHMIA
SCREENING OF DRUGS USED IN ANTIARRYTHMIASCREENING OF DRUGS USED IN ANTIARRYTHMIA
SCREENING OF DRUGS USED IN ANTIARRYTHMIASreyaRathnaj
 
screening of anxiolytics
screening of anxiolyticsscreening of anxiolytics
screening of anxiolyticsSayanti Sau
 
Screening of antiparkinson agent
Screening of antiparkinson agentScreening of antiparkinson agent
Screening of antiparkinson agentSONALPANDE5
 
screening methods for anti-atherosclerotic agents
screening methods for anti-atherosclerotic agentsscreening methods for anti-atherosclerotic agents
screening methods for anti-atherosclerotic agentsPrajitha p
 
Pharmacological screening of analgesic activity
Pharmacological screening of analgesic activityPharmacological screening of analgesic activity
Pharmacological screening of analgesic activityBiswash Sapkota
 
screening methods for Antiepileptic activity
screening methods for Antiepileptic activityscreening methods for Antiepileptic activity
screening methods for Antiepileptic activitySravanthi Shetty
 
Screening models for aphrodisiac agents and anti fertility agents
Screening models for aphrodisiac agents and anti fertility agentsScreening models for aphrodisiac agents and anti fertility agents
Screening models for aphrodisiac agents and anti fertility agentsCh. Bhargava krishna
 
Hepatoprotective screening methods
Hepatoprotective screening methodsHepatoprotective screening methods
Hepatoprotective screening methodsShobhiniChandel
 
Behavior and muscle coordination
Behavior and muscle coordinationBehavior and muscle coordination
Behavior and muscle coordinationBhupen Singh
 

What's hot (20)

Pharmacological screening of anti arrhythmic drug
Pharmacological screening of anti arrhythmic drugPharmacological screening of anti arrhythmic drug
Pharmacological screening of anti arrhythmic drug
 
Screening of Antihyperlipidemic drugs
Screening of Antihyperlipidemic drugsScreening of Antihyperlipidemic drugs
Screening of Antihyperlipidemic drugs
 
Screening Methods of Anti Anxiety Agents
Screening Methods of Anti Anxiety AgentsScreening Methods of Anti Anxiety Agents
Screening Methods of Anti Anxiety Agents
 
Antiulcer screening models
Antiulcer screening modelsAntiulcer screening models
Antiulcer screening models
 
Preclinical Screening of Antipsychotic Agents
Preclinical Screening of Antipsychotic Agents Preclinical Screening of Antipsychotic Agents
Preclinical Screening of Antipsychotic Agents
 
Experimental evaluation of anti arrhythmic drugs
Experimental evaluation of anti arrhythmic drugsExperimental evaluation of anti arrhythmic drugs
Experimental evaluation of anti arrhythmic drugs
 
pre clinical Screening for anti asthmatic drugs
pre clinical Screening  for anti asthmatic drugspre clinical Screening  for anti asthmatic drugs
pre clinical Screening for anti asthmatic drugs
 
Antidiabetic screening
Antidiabetic screeningAntidiabetic screening
Antidiabetic screening
 
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDScreening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
 
Evaluation of antiarrhythmicdrugs
Evaluation of antiarrhythmicdrugsEvaluation of antiarrhythmicdrugs
Evaluation of antiarrhythmicdrugs
 
Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugs
 
SCREENING OF DRUGS USED IN ANTIARRYTHMIA
SCREENING OF DRUGS USED IN ANTIARRYTHMIASCREENING OF DRUGS USED IN ANTIARRYTHMIA
SCREENING OF DRUGS USED IN ANTIARRYTHMIA
 
screening of anxiolytics
screening of anxiolyticsscreening of anxiolytics
screening of anxiolytics
 
Screening of antiparkinson agent
Screening of antiparkinson agentScreening of antiparkinson agent
Screening of antiparkinson agent
 
screening methods for anti-atherosclerotic agents
screening methods for anti-atherosclerotic agentsscreening methods for anti-atherosclerotic agents
screening methods for anti-atherosclerotic agents
 
Pharmacological screening of analgesic activity
Pharmacological screening of analgesic activityPharmacological screening of analgesic activity
Pharmacological screening of analgesic activity
 
screening methods for Antiepileptic activity
screening methods for Antiepileptic activityscreening methods for Antiepileptic activity
screening methods for Antiepileptic activity
 
Screening models for aphrodisiac agents and anti fertility agents
Screening models for aphrodisiac agents and anti fertility agentsScreening models for aphrodisiac agents and anti fertility agents
Screening models for aphrodisiac agents and anti fertility agents
 
Hepatoprotective screening methods
Hepatoprotective screening methodsHepatoprotective screening methods
Hepatoprotective screening methods
 
Behavior and muscle coordination
Behavior and muscle coordinationBehavior and muscle coordination
Behavior and muscle coordination
 

Similar to Pharmacological Screening of Anti Arrhythmic Drug

SCREENING MODELS FOR ANTI-ARRTHMICS AND ANTI-ANGINAL AGENTS.pptx
SCREENING MODELS FOR ANTI-ARRTHMICS AND ANTI-ANGINAL AGENTS.pptxSCREENING MODELS FOR ANTI-ARRTHMICS AND ANTI-ANGINAL AGENTS.pptx
SCREENING MODELS FOR ANTI-ARRTHMICS AND ANTI-ANGINAL AGENTS.pptxAnagha R Anil
 
Antiarrhytmics screening models.pptx
Antiarrhytmics screening models.pptxAntiarrhytmics screening models.pptx
Antiarrhytmics screening models.pptxsharanuGurikar
 
Evaluation methods of anti-aarhythmics
Evaluation methods of anti-aarhythmicsEvaluation methods of anti-aarhythmics
Evaluation methods of anti-aarhythmicsDr Nikita Ingale
 
Screening of anti anginal and anti-allergic drugs -autosaved-
Screening of anti anginal and anti-allergic drugs -autosaved-Screening of anti anginal and anti-allergic drugs -autosaved-
Screening of anti anginal and anti-allergic drugs -autosaved-Gurubarath1
 
Preclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptx
Preclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptxPreclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptx
Preclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptxAshish Kumar Jha
 
Cpr for adults
Cpr for adultsCpr for adults
Cpr for adultsSULE AKIN
 
PG Instruments (Pharmacology).pptx
PG Instruments (Pharmacology).pptxPG Instruments (Pharmacology).pptx
PG Instruments (Pharmacology).pptxdrarunsingh4
 
BASIC LIFE SUPPORT and ALS.pptx
BASIC LIFE SUPPORT and ALS.pptxBASIC LIFE SUPPORT and ALS.pptx
BASIC LIFE SUPPORT and ALS.pptxxamdathisbad
 
screening method of cardiovascular activity
screening method of cardiovascular activityscreening method of cardiovascular activity
screening method of cardiovascular activityArpitSuralkar
 
Evaluation of antiarrhythmic drugs (1)
Evaluation of antiarrhythmic drugs (1)Evaluation of antiarrhythmic drugs (1)
Evaluation of antiarrhythmic drugs (1)Nitin Shinde
 
ACLs review.ppt
ACLs review.pptACLs review.ppt
ACLs review.pptishragaish
 
Screening methods for antianginal & antimalarial drugs
Screening methods for antianginal & antimalarial drugsScreening methods for antianginal & antimalarial drugs
Screening methods for antianginal & antimalarial drugsCharu Pundir
 
cardiopulmonary resuscitation for students
cardiopulmonary resuscitation for studentscardiopulmonary resuscitation for students
cardiopulmonary resuscitation for studentsShahnaali
 
Nursing care of patients having conduction disorders
Nursing care of patients having conduction disordersNursing care of patients having conduction disorders
Nursing care of patients having conduction disordersPrincy Francis M
 
Advanced Cardiac Life Support
Advanced Cardiac Life SupportAdvanced Cardiac Life Support
Advanced Cardiac Life Supportmeducationdotnet
 

Similar to Pharmacological Screening of Anti Arrhythmic Drug (20)

SCREENING MODELS FOR ANTI-ARRTHMICS AND ANTI-ANGINAL AGENTS.pptx
SCREENING MODELS FOR ANTI-ARRTHMICS AND ANTI-ANGINAL AGENTS.pptxSCREENING MODELS FOR ANTI-ARRTHMICS AND ANTI-ANGINAL AGENTS.pptx
SCREENING MODELS FOR ANTI-ARRTHMICS AND ANTI-ANGINAL AGENTS.pptx
 
Antiarrhytmics screening models.pptx
Antiarrhytmics screening models.pptxAntiarrhytmics screening models.pptx
Antiarrhytmics screening models.pptx
 
Evaluation methods of anti-aarhythmics
Evaluation methods of anti-aarhythmicsEvaluation methods of anti-aarhythmics
Evaluation methods of anti-aarhythmics
 
Screening antianginal (1)
Screening antianginal (1)Screening antianginal (1)
Screening antianginal (1)
 
Screening of anti anginal and anti-allergic drugs -autosaved-
Screening of anti anginal and anti-allergic drugs -autosaved-Screening of anti anginal and anti-allergic drugs -autosaved-
Screening of anti anginal and anti-allergic drugs -autosaved-
 
TBR ACLS.pptx
TBR ACLS.pptxTBR ACLS.pptx
TBR ACLS.pptx
 
Preclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptx
Preclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptxPreclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptx
Preclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptx
 
Cpr for adults
Cpr for adultsCpr for adults
Cpr for adults
 
PG Instruments (Pharmacology).pptx
PG Instruments (Pharmacology).pptxPG Instruments (Pharmacology).pptx
PG Instruments (Pharmacology).pptx
 
BASIC LIFE SUPPORT and ALS.pptx
BASIC LIFE SUPPORT and ALS.pptxBASIC LIFE SUPPORT and ALS.pptx
BASIC LIFE SUPPORT and ALS.pptx
 
screening method of cardiovascular activity
screening method of cardiovascular activityscreening method of cardiovascular activity
screening method of cardiovascular activity
 
Evaluation of antiarrhythmic drugs (1)
Evaluation of antiarrhythmic drugs (1)Evaluation of antiarrhythmic drugs (1)
Evaluation of antiarrhythmic drugs (1)
 
ACLs review.ppt
ACLs review.pptACLs review.ppt
ACLs review.ppt
 
Screening methods for antianginal & antimalarial drugs
Screening methods for antianginal & antimalarial drugsScreening methods for antianginal & antimalarial drugs
Screening methods for antianginal & antimalarial drugs
 
cardiopulmonary resuscitation for students
cardiopulmonary resuscitation for studentscardiopulmonary resuscitation for students
cardiopulmonary resuscitation for students
 
Cardic emergency
Cardic emergencyCardic emergency
Cardic emergency
 
Defibrillator
DefibrillatorDefibrillator
Defibrillator
 
Nursing care of patients having conduction disorders
Nursing care of patients having conduction disordersNursing care of patients having conduction disorders
Nursing care of patients having conduction disorders
 
Lifepak 20 TTP
Lifepak 20 TTPLifepak 20 TTP
Lifepak 20 TTP
 
Advanced Cardiac Life Support
Advanced Cardiac Life SupportAdvanced Cardiac Life Support
Advanced Cardiac Life Support
 

Recently uploaded

STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCESTERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCEPRINCE C P
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.aasikanpl
 
Analytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfAnalytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfSwapnil Therkar
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)PraveenaKalaiselvan1
 
GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxAleenaTreesaSaji
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Lokesh Kothari
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxAArockiyaNisha
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsAArockiyaNisha
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )aarthirajkumar25
 
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdfNAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdfWadeK3
 
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxSOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxkessiyaTpeter
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoSérgio Sacani
 
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...Sérgio Sacani
 
Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Patrick Diehl
 
Nanoparticles synthesis and characterization​ ​
Nanoparticles synthesis and characterization​  ​Nanoparticles synthesis and characterization​  ​
Nanoparticles synthesis and characterization​ ​kaibalyasahoo82800
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...RohitNehra6
 
G9 Science Q4- Week 1-2 Projectile Motion.ppt
G9 Science Q4- Week 1-2 Projectile Motion.pptG9 Science Q4- Week 1-2 Projectile Motion.ppt
G9 Science Q4- Week 1-2 Projectile Motion.pptMAESTRELLAMesa2
 
Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTSérgio Sacani
 

Recently uploaded (20)

STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCESTERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
 
Analytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfAnalytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdf
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)
 
GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptx
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
 
The Philosophy of Science
The Philosophy of ScienceThe Philosophy of Science
The Philosophy of Science
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
 
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based Nanomaterials
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )
 
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdfNAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
 
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxSOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on Io
 
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
 
Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?
 
Nanoparticles synthesis and characterization​ ​
Nanoparticles synthesis and characterization​  ​Nanoparticles synthesis and characterization​  ​
Nanoparticles synthesis and characterization​ ​
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...
 
G9 Science Q4- Week 1-2 Projectile Motion.ppt
G9 Science Q4- Week 1-2 Projectile Motion.pptG9 Science Q4- Week 1-2 Projectile Motion.ppt
G9 Science Q4- Week 1-2 Projectile Motion.ppt
 
Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOST
 

Pharmacological Screening of Anti Arrhythmic Drug

  • 1. NOIDA INSTITUTE OF ENGINEERING AND TECHNOLOGY Pharmacological Screening of Anti Arrhythmic Drug Presented by- Submitted to- Jatin Saini Dr. Saumya Das M.Pharm (Pharmacology) Associate Professor 1st sem
  • 2. ARRHYTHMIA  A heart arrhythmia is an irregular heartbeat. Heart rhythm problems occur when the electrical signals that coordinate the heart's beats don't work properly.  The faulty signaling causes the heart to beat too fast (tachycardia), too slow (bradycardia) or irregularly..  Types • Tachycardia is a fast heart. The resting heart rate is greater than 100 beats a minute. • Bradycardia is a slow heartbeat. The resting heart rate is less than 60 beats a minute.
  • 3. Screening Model In vivo Model In vitro Model 1. CHEMICALLY INDUCED ARRHYTHMIA • Aconitine antagonism in rats • Digoxin induced arrhythmias in guine pigs • Strophanthin induced Arrhythmia • Adrenaline induced Arrhythmia 2. ELECTRICALLY INDUCED ARRHYTHMIA • Ventricular fibrillation electrical threshold. • Programmed Electrical Stimulation Induced Arrhythmia • Sudden Coronary Death Models in Dogs 3. EXERCISE INDUCED VENTRICULAR FIBRILATION 4. MECHANICALLY INDUCED ARRHYTHMIA 1. Reperfusion Arrhythmia in Rats 2. Reperfusion Arrhythmia in Dog 1. Acetylcholine or Potassium Induced Arrhythmias 2. LANGENDROFF Technique
  • 4. In vivo Model 1. Chemically Induced Arrhythmia  Large number of agents alone or combination are capable to induced arrhythmia:  Anesthetic like Chloroform, ether, Halothane.  IV Adrenaline, Ouabain alkaloids
  • 5. Aconitine antagonism in rats Purpose: Aconitine, its plant alkaloid from roots, it acts persistent on Na+ channels resulting ventricular arrhythmias. Drugs which have anti-arrhythmetic property can be tested on aconitine intoxicated rats. Procedure Male Ivanovas rats (300-400 gm) are used Anesthetized intraperitonially with urethane (1.25 g/kg) Aconitine dissolved (5 mcg/kg) in 0.1 N HNO, & infused into rat's saphenous vein 0.1 ml/min Lead II ECG is recorded every 30 sec. Test compound injected orally 5 min before Aconitine infusion Evaluation Higher dose of aconitine in the test group gives an index of antiarrhythmic activity. The antiarrhythmic effect of test compound is measured by the amount of aconitine /100g animal. Higher dose of aconitine is needed as compared with control group.
  • 6. Digoxin induced arrhythmias in guine pigs Purpose Overdose of cardiac glycosides, such as digoxin, induces ventricular extrasystoles, ventricular fibrillation, and finally death. The occurrence of these symptoms can be delayed by antiarrhythmic drugs. Procedure Male Marioth guinea pigs (350-500 g) anesthetize with pentobarbitone 35mg/kg intraperitonially Tracheae, Jugular vein & carotid artery catheterized & animal is maintained on artificial respiration (45 breath/min) Through jugular vein digoxin is infused at rate 85mcg/kg in 0.266 ml/min until cardiac arrest ECG recorded with steel needle during experiment Test drug is administered either 1hr before if orally or 1min before if IV, prior infusion of digoxine The onset of ventricular extrasystoles, fibrillation, cardiac arrest Compared results in test & control group Evalution Using Student’s t-test, the doses of digoxin needed to induce ventricular extrasystoles, fibrillation, or cardiac arrest, respectively after treatment with antiarrhythmic drugs are compared statistically with controls receiving digoxin only
  • 7. Electrically induced arrhythmia  Serial electrical stimulation results in flutter and fibrillation and it is possible to reproduce some of the main type of arrhythmias of clinical importance. The flutter threshold or the ventricular multiple response threshold may be determine in anesthetized dogs before or after administration of test drug. 1. Ventricular fibrillation electrical threshold 2. Programmed Electrical Stimulation Induced Arrhythmia 3. Sudden Coronary Death Models in Dogs
  • 8. Ventricular fibrillation electrical threshold Purpose The use of antiarrhythmic drugs in the treatment of ventricular arrhythmias aims to prevent the development of ventricular fibrillation. Several electrical stimulation techniques have been used to measure ventricular fibrillation threshold such as  single pulse stimulation,  train of pulses stimulation,  continuous 50 Hz stimulation,  sequential pulse stimulation
  • 9. Procedure  Dogs (8-12 kg) anesthetized with pentobarbitone intraperitonially and maintained on artificial  Chest opened & heart is suspended on pericardial cradle  SA node crushed & Ag-AgCl stimulating electrode embedded with Teflon disc sutured to anterior of LV  Anodal constant current for 400ms is applied through electrode and which was programmed by digital stimulator  ECG recorded through lead Il of body ECG monitoring  To determine Ventricular Fibrillation (VFT) 0.2 to 1.8 s train of 50Hz pulses delivered  The current intensity of pulse train required to induce sustained ventricular fibrillation is define as VFT  When VF occurs, heart immediately defibrillate & allow to recover as controlled condition for 15-20  Test drug administered through femoral vein Evaluation VFT is determined before and after administration of test drug & compared by using student T-Test
  • 10. EXERCISE INDUCED VENTRICULAR FIBRILATION Purpose: This developed methods to evaluate antiarrhythmic drugs for their activity in cardiovascular parameters in an exercise-plus ischemia test. Procedure:  Mongral dogs (15-19 kg) anesthetized with pentobarbitone IV (10mg/kg)  Chest cavity opened, heart exposed & supported with pericardial cradle  Around LCX 20 MHz pulsed Doppler flow transducer & hydraulic accluder are placed  Pair of insulated silver wire sutured to epicardial surface of both left and right ventricle. ECG & HR is determined  Pre calibrated solid state pressure transducer is inserted into left ventricle finally, a two stage occlusion of LAD is performed  Leads from cardiovascular instrumentation are tunneled under skin to exit on the back of animal's neck  3-4 weeks after the production of myocardial ischemia; animal are walked on treadmill & trained to lie quietly on lab table during recovery period
  • 11.  Protocol starts with 3 min warm up followed by run at 6.4 km/hr (0% grade)  Grade is increased every 3min run 0% 4% 8% 12% and 16%  During last min of exercise LCX is occlusion treadmill stopped & occlusion maintained for additional 1min  Occlusion is released if VF occurs  Exercise and ischemia test is repeated after pretreated with test drug & compared with control reading
  • 12. In vitro Model  Acetylcholine or Potassium Induced Arrhythmias  LANGENDROFF Technic
  • 13. Acetylcholine or Potassium Induced Arrhythmias  New Zealand white rabbits (0.5-3kg) sacrificed and heart removed  Atria dissected from other tissue in RL and attached with electrode  Fibrillation produced when atria exposed with Acetylcholine or KCL  After 5min exposure to Acetylcholine or KCL, atria stimulated with pulses 0.75 ms, usually of 100and recorded on kymograph  Control arrhythmia produced for 6-10 min followed by 30 min rest period  Test compound were added to the bath  If fibrillation doesn't disappear within 8-10 min, preparation is washed to allowed to normal concentration.  Test drug found to be effective If fibrillation is disappears immediately or within 5min
  • 14. LANGENDROFF Technique  Basic principal involved is that heart is perfused in RETROGRADE Direction from aorta either at constant pressure or constant flow with oxygenated saline solution. It closes aortic valves, just in situ heart during diastole. The perfusate is displaced through the coronary sinus and the opened right atrium.  Procedure  Guinea pigs either sex 300-500 g  Heart is removed ASAP and placed in petridish containing RL at 37.0°C Aorta located and cut below the division  Cannula inserted into the aorta and tied. Heart is perfused with oxygenated RL  Heart is transferred to double wall Plexiglass perfussion apparatus maintained 37.0°C  Ligature is placed around LAD coronary artery occlusion is maintained for 10 min by reperfussion  Test compound administered through perfusion medium either before or after occlusion.  Epicardial ECG electrode is used for pulsatile stimulation and induction of arrhythmia [Rectangular pulses 0.75 msec duration, 10 V, 400-1800 shocks/min]  Small steel hook with string attached to apex of heart and HR measured with chronometer  Incidence & duration of VF or VT is recorded in control & test group
  • 15. References  Drug Discoveryand Evaluation: pharmacological assays by H Gerhard Vogel  http://www.slideshare.net/DrAbhishekVyas/drug-screening-methods-for-antiarrhythmic- agents?from_m_app=android